Bibliotecas PUC-SP - Busca Integrada

Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease

Por Yoshihiro Inamoto, Paul J. Martin, Barry E. Storer, Marco Mielcarek, Rainer F. Storb, Paul A. Carpenter
Publicado no Haematologica (2014-02-01)

Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes

Por Janghee Woo, Nicholas P. Howard, Barry E. Storer, Min Fang, Cecilia C. Yeung, Bart L. Scott, H. Joachim Deeg
Publicado no Haematologica (2017-06-01)

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect

Por Enrico Maffini, Larry D. Anderson, Brenda M. Sandmaier, Damian J. Green, Barry E. Storer, Dietger Niederwieser, Richard T. Maziarz, David G. Maloney, Rainer Storb
Publicado no Haematologica (2018-06-01)

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

Por Marco Mielcarek, Terrence Furlong, Barry E. Storer, Margaret L. Green, George B. McDonald, Paul A. Carpenter, Mary E.D. Flowers, Rainer Storb, Michael Boeckh, Paul J. Martin
Publicado no Haematologica (2015-06-01)

Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferativ...

Por Federico Monaco, Bart L. Scott, Thomas R. Chauncey, Finn B. Petersen, Barry E. Storer, Frederic Baron, Mary E. Flowers, H. Joachim Deeg, David G. Maloney, Rainer Storb, Brenda M. Sandmaier
Publicado no Haematologica (2019-06-01)

Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia

Por Janghee Woo, Dae Ro Choi, Barry E. Storer, Cecilia Yeung, Anna B. Halpern, Rachel B. Salit, Mohamed L. Sorror, David W. Woolston, Tim Monahan, Bart L. Scott, H. Joachim Deeg
Publicado no Haematologica (2020-03-01)

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma

Por Damian J. Green, David G. Maloney, Barry E. Storer, Brenda M. Sandmaier, Leona A. Holmberg, Pamela S. Becker, Min Fang, Paul J. Martin, George E. Georges, Michelle E. Bouvier, Rainer Storb, Marco Mielcarek
Publicado no Blood Advances (2017-11-01)

Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation

Por Giancarlo Fatobene, Barry E. Storer, Rachel B. Salit, Stephanie J. Lee, Paul J. Martin, Guang-Shing Cheng, Paul A. Carpenter, Gansuvd Balgansuren, Effie W. Petersdorf, Colleen Delaney, Brenda M. Sandmaier, Filippo Milano, Mary E. Flowers
Publicado no Haematologica (2019-04-01)

Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease

Por Yoshihiro Inamoto, Paul J. Martin, Barry E. Storer, Jeanne Palmer, Daniel J. Weisdorf, Joseph Pidala, Mary E. D. Flowers, Mukta Arora, Madan Jagasia, Sally Arai, Xiaoyu Chai, Steven Z. Pavletic, Georgia B. Vogelsang, Stephanie J. Lee
Publicado no Haematologica (2014-10-01)

A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation

Por Paul J. Martin, Paul J. Martin, David M. Levine, Barry E. Storer, Xiuwen Zheng, Deepti Jain, Ben Heavner, Brandon M. Norris, Daniel E. Geraghty, Stephen R. Spellman, Cassie L. Sather, Feinan Wu, John A. Hansen, John A. Hansen
Publicado no Frontiers in Immunology (2021-11-01)

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

Por Enrico Maffini, Barry E. Storer, Brenda M. Sandmaier, Benedetto Bruno, Firoozeh Sahebi, Judith A. Shizuru, Thomas R. Chauncey, Parameswaran Hari, Thoralf Lange, Michael A. Pulsipher, Peter A. McSweeney, Leona Holmberg, Pamela S. Becker, Damian J. Green, Marco Mielcarek, David G. Maloney, Rainer Storb
Publicado no Haematologica (2019-02-01)

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

Por Brian Kornblit, David G. Maloney, Barry E. Storer, Michael B. Maris, Lars Vindeløv, Parameswaran Hari, Amelia A. Langston, Michael A. Pulsipher, Wolfgang A. Bethge, Thomas R. Chauncey, Thoralf Lange, Finn B. Petersen, Kai Hübel, Ann E. Woolfrey, Mary E.D. Flowers, Rainer Storb, Brenda M. Sandmaier
Publicado no Haematologica (2014-10-01)

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades

Por Jason P. Cooper, Barry E. Storer, Noa Granot, Boglark Gyurkocza, Mohamed L. Sorror, Thomas R. Chauncey, Judith Shizuru, Georg-Nikolaus Franke, Michael B. Maris, Michael Boyer, Benedetto Bruno, Firoozeh Sahebi, Amelia A. Langston, Parameswaran Hari, Edward D. Agura, Søren Lykke Petersen, Richard T. Maziarz, Wolfgang Bethge, Julie Asch, Jonathan A. Gutman, Gitte Olesen, Andrew M. Yeager, Kai Hübel, William J. Hogan, David G. Maloney, Marco Mielcarek, Paul J. Martin, Mary E.D. Flowers, George E. Georges, Ann E. Woolfrey, H. Joachim Deeg, Bart L. Scott, George B. McDonald, Rainer Storb, Brenda M. Sandmaier
Publicado no Haematologica (2020-06-01)